Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L L Johnson

Showing results (181-190 of 194) with videos related to

Pageof 20
Sort By:
The Journal of Biological Chemistry|February 23, 1996
The structural basis for the elastolytic activity of the 92-kDa and 72-kDa gelatinases. Role of the fibronectin type II-like repeatsJ M Shipley, G A Doyle, C J Fliszar, et al.
Nature Immunology|March 23, 2001
Reciprocal regulation of polarized cytokine production by effector B and T cellsD P Harris, L Haynes, P C Sayles, et al.
The Journal of Biological Chemistry|February 7, 2001
A rationalization of the acidic pH dependence for stromelysin-1 (Matrix metalloproteinase-3) catalysis and inhibitionL L Johnson, A G Pavlovsky, A R Johnson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1992
Imaging of cardiac transplantation rejection in primates using two new antimyosin agentsR A Vaccarino, J E Sanchez, L L Johnson, et al.
Drug Design and Discovery|April 1, 1996
Designing inhibitors of the metalloproteinase superfamily: comparative analysis of representative structuresV Dhanaraj, Q Z Ye, L L Johnson, et al.
Structure (London, England : 1993)|April 15, 1996
X-ray structure of a hydroxamate inhibitor complex of stromelysin catalytic domain and its comparison with members of the zinc metalloproteinase superfamilyV Dhanaraj, Q Z Ye, L L Johnson, et al.
Journal of the American College of Cardiology|January 1, 1989
Antimyosin imaging in acute transmural myocardial infarctions: results of a multicenter clinical trialL L Johnson, D W Seldin, L C Becker, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|July 21, 2005
No association between alcohol supplementation and autoantibodies to DNA damage in postmenopausal women in a controlled feeding studyS Mahabir, D J Baer, L L Johnson, et al.
Journal of Medicinal Chemistry|January 29, 2000
Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitorsP M O'Brien, D F Ortwine, A G Pavlovsky, et al.
Circulation|July 1, 1987
Measurement of infarct size and percentage myocardium infarcted in a dog preparation with single photon-emission computed tomography, thallium-201, and indium 111-monoclonal antimyosin FabL L Johnson, K S Lerrick, J Coromilas, et al.
Pageof 20

Showing results (181-190 of 194) with videos related to

Sort By:
Pageof 20
The Journal of Biological Chemistry|February 23, 1996
The structural basis for the elastolytic activity of the 92-kDa and 72-kDa gelatinases. Role of the fibronectin type II-like repeatsJ M Shipley, G A Doyle, C J Fliszar, et al.
Nature Immunology|March 23, 2001
Reciprocal regulation of polarized cytokine production by effector B and T cellsD P Harris, L Haynes, P C Sayles, et al.
The Journal of Biological Chemistry|February 7, 2001
A rationalization of the acidic pH dependence for stromelysin-1 (Matrix metalloproteinase-3) catalysis and inhibitionL L Johnson, A G Pavlovsky, A R Johnson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1992
Imaging of cardiac transplantation rejection in primates using two new antimyosin agentsR A Vaccarino, J E Sanchez, L L Johnson, et al.
Drug Design and Discovery|April 1, 1996
Designing inhibitors of the metalloproteinase superfamily: comparative analysis of representative structuresV Dhanaraj, Q Z Ye, L L Johnson, et al.
Structure (London, England : 1993)|April 15, 1996
X-ray structure of a hydroxamate inhibitor complex of stromelysin catalytic domain and its comparison with members of the zinc metalloproteinase superfamilyV Dhanaraj, Q Z Ye, L L Johnson, et al.
Journal of the American College of Cardiology|January 1, 1989
Antimyosin imaging in acute transmural myocardial infarctions: results of a multicenter clinical trialL L Johnson, D W Seldin, L C Becker, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|July 21, 2005
No association between alcohol supplementation and autoantibodies to DNA damage in postmenopausal women in a controlled feeding studyS Mahabir, D J Baer, L L Johnson, et al.
Journal of Medicinal Chemistry|January 29, 2000
Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitorsP M O'Brien, D F Ortwine, A G Pavlovsky, et al.
Circulation|July 1, 1987
Measurement of infarct size and percentage myocardium infarcted in a dog preparation with single photon-emission computed tomography, thallium-201, and indium 111-monoclonal antimyosin FabL L Johnson, K S Lerrick, J Coromilas, et al.
Pageof 20